3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Unknown
2
Completed
2
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Urinary Bladder Neoplasms
2
Recurrence
1
Interventions
Gemcitabine
7
Cystectomy
5
Cisplatin
5
durvalumab
4
Neoadjuvant Therapy
4
Mitomycin
4
atezolizumab
3
Transurethral Resection of Bladder
3
Nivolumab
3
Epirubicin
3
Chemoradiotherapy
3
BCG Vaccine
3
Anesthesia, Spinal
3
tislelizumab
2
disitamab vedotin
2
catumaxomab
2
Vitamin E
2
Urinary Diversion
2
Sunitinib
2
Selenium
2
Robotic Surgical Procedures
2
Multiparametric Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Immunohistochemistry
2
Fentanyl
2
Docetaxel
2
Diathermy
2
Cystoscopy
2
Chemoprevention
2
BCG Connaught
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Urinary Bladder Neoplasms
×
BCG Connaught
×
Clear all
NCT02948543
2023-06-18
BCG+MM
University of Sydney
Phase 3
Unknown
501 enrolled
NCT03664869
2021-04-01
FB10
Turku University Hospital
Phase 3
Unknown
300 enrolled